Medical Weight Loss for Lawrence, Indiana Residents
Lawrence, Indiana residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Lawrence through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Lawrence Residents Choose New Hope Weight Loss
New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, California that has treated over 5,400 patients since 2020. We serve Lawrence, Indiana through telehealth at some of the most transparent prices anywhere, semaglutide from $166/month and tirzepatide from $233/month · just $7.70/day. No insurance battles, no hidden fees. Care is overseen by Dr. Anjmun Sharma, M.D.
Medical weight loss for Lawrence is handled end-to-end online: intake, the $119 physician review with Dr. Sharma, dose titration, and follow-ups, all by secure video, with no drive and no pharmacy line.
In Lawrence, Indiana, you do not need a local clinic to begin: our physician-led program reaches you by telehealth. We care for patients throughout Lawrence and the northeastern Indianapolis metro area of Marion County. There is no distance surcharge for Lawrence patients, and HSA, FSA, Klarna, and Affirm are all accepted.
Whether you live in central Lawrence or its outskirts, you get exactly the same care and the same price. Compounded medication arrives in discreet, cold-pack packaging at your Lawrence address, usually within days.
GLP-1 Weight Loss Programs Available
Compounded semaglutide, from $166/mo (90-day program $499)
The 90-day Metabolic Reset is our most-chosen plan. Semaglutide shares its active ingredient with Wegovy® and Ozempic®; in trials of the branded drug, patients lost an average of 15-17% of body weight under physician supervision.
Compounded tirzepatide, from $233/mo
Tirzepatide's dual GLP-1/GIP action reached up to 22.5% body-weight loss in trials of the branded medication, the advanced option for Lawrence patients.
The physician review is a flat $119, with medication billed separately; HSA, FSA, Klarna, and Affirm are accepted.
How Telehealth Works for Lawrence
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Lawrence address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Lawrence
Does New Hope Weight Loss treat patients in Lawrence?
Yes. Although the clinic is in Costa Mesa, California, we treat Lawrence, Indiana residents by telehealth, Dr. Sharma reviews your case by secure video and compounded medication ships to your home. Eligibility is confirmed during the consultation.
Do I have to travel to get started from Lawrence?
No travel is needed. The whole process, intake, consultation, and follow-ups, is by secure video, and your medication arrives at your Lawrence address in cold-pack packaging.
What do Lawrence patients pay?
Flat nationwide pricing: $119 for the physician review, then semaglutide from $166/month and tirzepatide from $233/month, medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, with no distance surcharge.
What areas of Lawrence do you serve?
We serve patients from across Lawrence by telehealth, including Lawrence and the northeastern Indianapolis metro area of Marion County.
Is my health information private as a Lawrence patient?
Yes. Your intake, video visits, and records are handled under HIPAA safeguards, and medication arrives in discreet packaging. Lawrence patients get the same confidentiality as any telehealth patient.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Lawrence, Indiana by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.